HK1211832A1 - 用於癌症療法的抗高血壓藥物的新穎配方及用法 - Google Patents

用於癌症療法的抗高血壓藥物的新穎配方及用法

Info

Publication number
HK1211832A1
HK1211832A1 HK15110912.7A HK15110912A HK1211832A1 HK 1211832 A1 HK1211832 A1 HK 1211832A1 HK 15110912 A HK15110912 A HK 15110912A HK 1211832 A1 HK1211832 A1 HK 1211832A1
Authority
HK
Hong Kong
Prior art keywords
cancer therapy
novel compositions
hypertension agents
hypertension
agents
Prior art date
Application number
HK15110912.7A
Other languages
English (en)
Chinese (zh)
Inventor
Rakesh Kumar Jain
Yves Boucher
Vikash Pal Singh Chauhan
Benjamin Diop-Frimpong
Stephen Krane
Alan L Crane
Robert Samuel Langer
Original Assignee
Massachusetts Gen Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/834,094 external-priority patent/US20130287688A1/en
Application filed by Massachusetts Gen Hospital filed Critical Massachusetts Gen Hospital
Publication of HK1211832A1 publication Critical patent/HK1211832A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15110912.7A 2012-05-07 2015-11-05 用於癌症療法的抗高血壓藥物的新穎配方及用法 HK1211832A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261643487P 2012-05-07 2012-05-07
US13/834,094 US20130287688A1 (en) 2010-11-18 2013-03-15 Novel compositions and uses of anti-hypertension agents for cancer therapy
PCT/US2013/039901 WO2013169739A1 (en) 2012-05-07 2013-05-07 Novel compositions and uses of anti-hypertension agents for cancer therapy

Publications (1)

Publication Number Publication Date
HK1211832A1 true HK1211832A1 (zh) 2016-10-14

Family

ID=49551209

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110912.7A HK1211832A1 (zh) 2012-05-07 2015-11-05 用於癌症療法的抗高血壓藥物的新穎配方及用法

Country Status (5)

Country Link
EP (1) EP2866791A4 (de)
AU (2) AU2013259772A1 (de)
CA (1) CA2872652A1 (de)
HK (1) HK1211832A1 (de)
WO (1) WO2013169739A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9381253B2 (en) 2013-04-09 2016-07-05 Massachusetts Institute Of Technology Drug delivery polymer and uses thereof
WO2017077425A1 (en) * 2015-11-07 2017-05-11 Ftf Pharma Private Limited Oral solution of ace inhibitors
US11433136B2 (en) 2015-12-18 2022-09-06 The General Hospital Corporation Polyacetal polymers, conjugates, particles and uses thereof
WO2017214337A1 (en) 2016-06-07 2017-12-14 Massachusetts Institute Of Technology Drug delivery polymers and uses thereof
WO2018039577A1 (en) 2016-08-26 2018-03-01 Massachusetts Institute Of Technology Bottlebrush polymers and uses thereof
WO2018067702A1 (en) 2016-10-04 2018-04-12 Massachusetts Institute Of Technology Bottlebrush copolymers and uses thereof
WO2018106738A1 (en) 2016-12-05 2018-06-14 Massachusetts Institute Of Technology Brush-arm star polymers, conjugates and particles, and uses thereof
JP2020501589A (ja) * 2016-12-23 2020-01-23 ウイルツ・バイオロジクス・リミテッド がんの治療
US11155674B2 (en) 2017-01-20 2021-10-26 Massachusetts Institute Of Technology Polymerizable sulfonamide compounds and polymers thereof
US11034788B2 (en) 2017-01-20 2021-06-15 Massachusetts Institute Of Technology Polymers and uses thereof
WO2019006425A1 (en) 2017-06-30 2019-01-03 Massachusetts Institute Of Technology IMAGING AGENTS OF BRUSH ARRAY STAR POLYMERS AND USES THEREOF
EP3645600A1 (de) 2017-06-30 2020-05-06 Massachusetts Institute of Technology Kern-zu-oberfläche-polymerisation zur synthese von sternpolymeren und deren verwendung
EP3645530A2 (de) 2017-06-30 2020-05-06 Massachusetts Institute of Technology Verzweigte multifunktionelle makromonomere und verwandte polymere und deren verwendung
CA3129412A1 (en) 2018-04-13 2019-10-17 Massachusetts Institute Of Technology Brush prodrugs and uses thereof
US10988491B2 (en) 2018-08-17 2021-04-27 Massachusetts Institute Of Technology Degradable polymers of a cyclic silyl ether and uses thereof
EP3972982A1 (de) 2019-05-20 2022-03-30 Massachusetts Institute of Technology Boronester-prodrugs und verwendungen davon
AU2020368453A1 (en) 2019-10-16 2022-04-21 Massachusetts Institute Of Technology Brush prodrugs and uses thereof
BR112022008753A2 (pt) 2019-11-06 2022-07-19 Remedy Plan Inc Tratamentos de câncer direcionados a células-tronco cancerosas
WO2021141662A1 (en) 2020-01-10 2021-07-15 Massachusetts Institute Of Technology Proteolysis targeting chimeric molecules (protacs) with functional handles and uses thereof
JP2024518089A (ja) 2021-05-13 2024-04-24 リメディー プラン，インコーポレーテッド Ｎａｍｐｔ阻害剤とその使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458767B1 (en) * 1994-05-04 2002-10-01 The Uab Research Foundation Use of peptides inhibitory for thrombospondin dependent TGF-β activation in the treatment of kidney disease
AU771635B2 (en) * 1999-01-05 2004-04-01 American National Red Cross, The Methods for treating conditions associated with the accumulation of excess extracellular matrix
EP1990049A3 (de) * 2005-03-21 2008-11-26 Vicus Therapeutics SPE 1, LLC Kombinationstherapie von Beta-Blockern und nicht steroidalen antiinflammatorischen Antiphlogistika/Antirheumatika (NSAR)
DE102005039579B4 (de) * 2005-08-19 2022-06-30 Magforce Ag Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
CA2668725A1 (en) * 2006-11-09 2008-05-22 Ore Pharmaceuticals Inc. Breast cancer screening and treatment methods
US20090297621A1 (en) * 2008-06-03 2009-12-03 Abbott Cardiovascular Systems Inc. Microparticles For The Treatment Of Disease
CN101612400A (zh) * 2009-07-22 2009-12-30 陈志龙 血管紧张素ⅱ的1型受体拮抗剂在抗肿瘤中的应用
US8238519B2 (en) * 2010-07-12 2012-08-07 Siemens Medical Solutions Usa, Inc. Rotational radiation treatment of moving targets
AU2011329638C1 (en) * 2010-11-18 2017-04-27 The General Hospital Corporation Novel compositions and uses of anti-hypertension agents for cancer therapy

Also Published As

Publication number Publication date
EP2866791A1 (de) 2015-05-06
AU2013259772A1 (en) 2014-12-04
WO2013169739A1 (en) 2013-11-14
EP2866791A4 (de) 2016-04-20
AU2018200448A1 (en) 2018-02-15
CA2872652A1 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
HK1211832A1 (zh) 用於癌症療法的抗高血壓藥物的新穎配方及用法
EP2640359A4 (de) Neue zusammensetzungen und verwendungen blutdrucksenkender mittel zur krebstherapie
HK1213798A1 (zh) 治療性化合物和組合物
PL2818482T3 (pl) Kompozycja farmaceutyczna do leczenia nowotworu
HK1202253A1 (en) Combination treatment of cancer
PT2824114T (pt) Composição farmacêutica para o tratamento do cancro
IL238177A0 (en) Methods and preparations for the treatment of cancer
EP2688594A4 (de) Verfahren und zusammensetzungen zur krebsbehandlung
HK1200739A1 (en) Diagnostic methods and compositions for treatment of cancer
EP2884984A4 (de) Therapeutische zusammensetzungen und verfahren
HK1214128A1 (zh) 癌症的治療
HK1205254A1 (en) Methods of treatment of cancer
EP2806894A4 (de) Verfahren und zusammensetzungen für therapeutika
GB201217892D0 (en) Treatment of cancer
HK1204956A1 (en) Treatment of cancer
SI2892925T1 (sl) Kombinacijsko zdravljenje raka
EP2928456A4 (de) Verfahren und zusammensetzungen für die behandlung von krebs
EP2895186A4 (de) Therapeutische zusammensetzungen und zugehörige verfahren
EP2897607A4 (de) Beta-hydrolase-hemmer zur behandlung von krebs
SG11201504779YA (en) Methods and compositions relating to treatment of cancer
GB201217890D0 (en) Treatment of cancer
GB201222952D0 (en) Treatent of cancer
GB201222949D0 (en) Combination Treatment of Cancer
GB201222950D0 (en) Combination treatment of cancer
GB201208296D0 (en) Treatment of cancer